Suppr超能文献

头孢哌酮对从社区医院分离出的厌氧菌的体外活性比较

Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.

作者信息

Goldstein E J, Citron D M

出版信息

Antimicrob Agents Chemother. 1985 Feb;27(2):162-6. doi: 10.1128/AAC.27.2.162.

Abstract

The activity of cefbuperazone against 266 strains of anaerobic bacteria was determined by the agar dilution method and compared with cefoxitin, moxalactam, piperacillin, and clindamycin. All strains were recent clinical isolates from community hospitals. All agents tested showed good activity against Bacteroides fragilis, Fusobacterium spp., Propionibacterium spp., Clostridium septicum, Clostridium perfringens, and the anaerobic, gram-positive cocci and gram-negative cocci. Cefbuperazone, cefoxitin, and moxalactam had poor activity against Bacteroides thetaiotaomicron, Bacteroides ovatus, and Bacteroides distasonis. The susceptibility of other Clostridium spp., Lactobacillus spp., and Eubacterium lentum was variable. Our community hospital isolates showed a difference in susceptibility patterns from those reported from university and research centers. This supports the recommendation that clinical microbiology laboratories, including those in community hospitals, need to perform susceptibility testing on representative clinical isolates.

摘要

采用琼脂稀释法测定了头孢哌酮对266株厌氧菌的活性,并与头孢西丁、拉氧头孢、哌拉西林和克林霉素进行了比较。所有菌株均为近期社区医院的临床分离株。所有受试药物对脆弱拟杆菌、梭杆菌属、丙酸杆菌属、败血梭菌、产气荚膜梭菌以及厌氧革兰氏阳性球菌和革兰氏阴性球菌均显示出良好的活性。头孢哌酮、头孢西丁和拉氧头孢对多形拟杆菌、卵形拟杆菌和狄氏拟杆菌的活性较差。其他梭菌属、乳杆菌属和迟缓真杆菌的敏感性各不相同。我们社区医院的分离株与大学和研究中心报告的分离株在药敏模式上存在差异。这支持了如下建议,即包括社区医院在内的临床微生物实验室需要对具有代表性的临床分离株进行药敏试验。

相似文献

1
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Antimicrob Agents Chemother. 1985 Feb;27(2):162-6. doi: 10.1128/AAC.27.2.162.
2
In vitro activity of cefbuperazone against anaerobic bacteria.
Antimicrob Agents Chemother. 1985 Apr;27(4):674-6. doi: 10.1128/AAC.27.4.674.
3
In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
Antimicrob Agents Chemother. 1985 May;27(5):749-52. doi: 10.1128/AAC.27.5.749.
4
In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.
Antimicrob Agents Chemother. 1985 Apr;27(4):640-2. doi: 10.1128/AAC.27.4.640.
6
Activity of cefotetan against anaerobic bacteria.
Diagn Microbiol Infect Dis. 1986 Apr;4(4):359-63. doi: 10.1016/0732-8893(86)90079-9.
8
Activity of cefmetazole against anaerobic bacteria.
Antimicrob Agents Chemother. 1987 Dec;31(12):2010-2. doi: 10.1128/AAC.31.12.2010.
9
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Antimicrob Agents Chemother. 1980 May;17(5):901-4. doi: 10.1128/AAC.17.5.901.

引用本文的文献

1
In vitro antibacterial effects of cephalosporins.
Drugs. 1987;34 Suppl 2:44-63. doi: 10.2165/00003495-198700342-00006.

本文引用的文献

1
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
Antimicrob Agents Chemother. 1981 Nov;20(5):600-9. doi: 10.1128/AAC.20.5.600.
3
In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
Antimicrob Agents Chemother. 1982 Nov;22(5):728-34. doi: 10.1128/AAC.22.5.728.
4
Susceptibility of the Bacteroides fragilis group in the United States in 1981.
Antimicrob Agents Chemother. 1983 Apr;23(4):536-40. doi: 10.1128/AAC.23.4.536.
5
Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents.
Antimicrob Agents Chemother. 1983 Sep;24(3):347-52. doi: 10.1128/AAC.24.3.347.
6
Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics.
Antimicrob Agents Chemother. 1980 Jun;17(6):957-60. doi: 10.1128/AAC.17.6.957.
7
9
Abdominal trauma, anaerobes, and antibiotics.
Surg Gynecol Obstet. 1973 Aug;137(2):270-6.
10
Management of anaerobic infections.
Ann Intern Med. 1975 Sep;83(3):375-89. doi: 10.7326/0003-4819-83-3-375.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验